Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 02/19

Trade details

Type: Insider sale
Amount: $32,201.4
Shares · price: 1,230 sh · $26.18 a share
Held after: 22,647 sh
Stock: Enliven Therapeutics ELVN
Person: Richard A. HeymanDirector
Trade date: 26/02/17
Filed: 26/02/19
Days to filing: 2 days

Sold 5.2% of holdings

Share of holding sold: 5.2%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Richard A. Heyman's recent trades

Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$45.2K
3,500 sh
$45.2K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$41.3K
3,200 sh
$41.3K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$109.1K
8,100 sh
$109.1K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$102.4K
7,600 sh
$102.4K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04